Tag Archives: cancer

Conference on Cancer by YLS and Smilow

https://law.yale.edu/solomon-center/events/policy-politics-and-law-cancer

Panels of interest below + Siddhartha Mukherjee and NCI Director are keynote speakers.

The Solomon Center for Health Law and Policy at Yale Law School, in collaboration with Smilow Cancer Hospital and Yale Cancer Center, will host a major interdisciplinary conference addressing topics at the cutting edge of cancer policy. This event will bring together leading figures in the worlds of cancer care, research, regulation, and policymaking to assess the current state of cancer policy and discuss ways in which law can influence its development.

Panel 3: Cancer, Health Justice, and Disparities

Moderators:
Cary Gross, MD—Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine
Eugene Rusyn, JD—Yale Law School

Panelists:

  • Dayna Bowen Matthew, JD—William J. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
  • Otis Brawley, MD—Chief Medical Officer, American Cancer Society
  • Blase Polite, MD—Associate Professor of Medicine, University of Chicago Medical Center
  • Deborah Schrag, MD, MPH—Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
  • Lindsay Wiley, JD, MPH—Professor of Law and Director, Health Law and Policy, Program, American University Washington College of Law

Panel 4: Drug Development and the Cost of Researching and Treating Cancer

Co-Moderators/Panelists:
Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
Aaron Kesselheim, MD, JD, MPH—Associate Professor of Medicine, Harvard Medical School

Panelists:

  • Peter Bach, MD, MAPP—Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Gideon Blumenthal, MD—Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
  • Levi Garraway, JD, PhD—Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
  • Amy Kapczynski, JD—Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
  • Jeffrey Schwartz, MBA—Managing Director, Bain Capital Life Sciences
  • Ellen Sigal, PhD—Chairperson and Founder, Friends of Cancer Research

Genes, environment, and “bad luck” | Science

Quite relevant….
==

Genes, environment & bad luck
http://science.ScienceMag.org/content/355/6331/1266 To what degree are #cancer mutations due to replication error (3rd factor), not 1st 2?

discusses R v D correlation

Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention Cristian Tomasetti1,2,*, Lu Li2, Bert Vogelstein3,*
Science 24 Mar 2017:
Vol. 355, Issue 6331, pp. 1330-1334
DOI: 10.1126/science.aaf9011
http://science.sciencemag.org/content/355/6331/1330